Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCAPDEVIELLE, Delphine
dc.contributor.authorNORTON, Joanna
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorAOUIZERATE, Bruno
IDREF: 069471851
dc.contributor.authorBERNA, Fabrice
dc.contributor.authorCHEREAU, Isabelle
dc.contributor.authorD'AMATO, Thierry
dc.contributor.authorDUBERTRET, Caroline
dc.contributor.authorDUBREUCQ, Julien
dc.contributor.authorFOND, Guillaume
dc.contributor.authorLANCON, Christophe
dc.contributor.authorMALLET, Jasmina
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorMISDRAHI, David
dc.contributor.authorPASSERIEUX, Catherine
dc.contributor.authorREY, Romain
dc.contributor.authorSCHURHOFF, Franck
dc.contributor.authorURBACH, Mathieu
dc.contributor.authorLLORCA, Pierre-Michel
dc.contributor.authorRAFFARD, Stephane
dc.date.accessioned2021-10-19T14:51:59Z
dc.date.available2021-10-19T14:51:59Z
dc.date.issued2021
dc.identifier.issn0165-1781en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112817
dc.description.abstractEnThe aim of our study was to compare the performance of three different instruments measuring clinical and cognitive dimensions of insight. Data on 182 outpatients with schizophrenia and one-year follow-up assessments was drawn from the FACE-SZ cohort. Awareness of clinical state (« clinical insight ») was measured using both a clinician-rated measure (the Scale to assess Unawareness of Mental Disorder (SUMD)), and a self-report measure (the Birchwood Insight Scale (BIS). Cognitive insight was measured using a self-report measure (the Beck Cognitive Insight Scale (BCIS)). For each scale, change in insight was examined at the follow-up. Correlations between SUMD and BIS subscales measuring same dimensions were significant. BIS-BCIS correlations were weak for all combinations except between BIS illness dimension and BCIS composite score. At the follow-up, BIS and SUMD awareness of treatment need improved whereas illness and symptom awareness increased only on the SUMD. Conversely, cognitive insight composite scores decreased. Despite relatively good overall agreement between the two clinical insight instruments, considerable variability for similar insight dimensions measured by different instruments was found. Agreement between cognitive and clinical insight is moderate. Our study strengthens the argument that insight is harder to operationalize than other symptoms and may explain why it is so seldom explicitly targeted in schizophrenia treatment.
dc.language.isoENen_US
dc.subject.enClinical Insight
dc.subject.enCognitive Insight
dc.subject.enInsight
dc.subject.enSchizophrenia
dc.title.enComparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.psychres.2021.114044en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed34161854en_US
bordeaux.journalPsychiatry Researchen_US
bordeaux.volume303en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.teamPsychoneuroimmunologie et Nutrition: Approches expérimentales et cliniquesen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Psychiatry%20Research&rft.date=2021&rft.volume=303&rft.eissn=0165-1781&rft.issn=0165-1781&rft.au=CAPDEVIELLE,%20Delphine&NORTON,%20Joanna&AOUIZERATE,%20Bruno&BERNA,%20Fabrice&CHEREAU,%20Isabelle&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée